Accuretic

   
Google
 
Web NewDrugInformation.com

Accuretic


Drug - Accuretic
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydrochlorothiazide; Quinapril Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 12.5MG;EQ 20MG BASE
The potency of the active ingredient(s), Hydrochlorothiazide; Quinapril Hydrochloride. May repeat for multiple part products.

Applicant - PFIZER PHARMS
The firm name holding legal responsibility for Accuretic. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020125
The FDA assigned number to Accuretic. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Accuretic. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 28, 1999
The date Accuretic was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Accuretic. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Accuretic is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pfizer Pharmaceuticals Ltd
The full name of the firm holding legal responsibility for the new application of Accuretic.

Accuretic